Trial intelligence / Profile preview

Safety Evaluation of D-TRANS Fentanyl with Naltrexone in Opioid Tolerant Patients

NCT00650182Phase 2Completed

Sponsor
ALZA Corporation
Start
Jan 2003
Modality
Orthosteric Ligands
01

Overview

A Phase 2 trial of fentanyl, naltrexone in chronic pain, sponsored by ALZA Corporation. Started Jan 2003; status: completed.

02

Drugs

fentanylnaltrexone
03

Conditions

chronic pain

Beyond the preview

Go deeper on NCT00650182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00650182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call